RetractedArticleJournal of enzyme inhibition and medicinal chemistry2023

Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.

Xiaopeng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.